TVGN - Tevogen Bio Holdings Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.47 -0.02 (-4.05%) --- 0.0 (0.19%) 0.0 (0.43%) -0.06 (-12.05%) 0.03 (7.78%) 0.04 (9.78%) 0.0 (0.02%)

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.03
Diluted EPS:
-0.03
Basic P/E:
-15.0283
Diluted P/E:
-15.0283
RSI(14) 1m:
54.15
VWAP:
0.45
RVol:

Events

Period Kind Movement Occurred At

Related News